Universal Biosensors Inc (UBI) - Total Assets

Latest as of June 2025: AU$14.94 Million AUD ≈ $10.57 Million USD

Based on the latest financial reports, Universal Biosensors Inc (UBI) holds total assets worth AU$14.94 Million AUD (≈ $10.57 Million USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check Universal Biosensors Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Universal Biosensors Inc - Total Assets Trend (2002–2024)

This chart illustrates how Universal Biosensors Inc's total assets have evolved over time, based on quarterly financial data. Check Universal Biosensors Inc (UBI) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Universal Biosensors Inc - Asset Composition Analysis

Current Asset Composition (December 2024)

Universal Biosensors Inc's total assets of AU$14.94 Million consist of 71.5% current assets and 28.5% non-current assets.

Asset Category	Amount (AUD)	% of Total Assets
Cash & Equivalents	AU$8.54 Million	33.1%
Accounts Receivable	AU$3.14 Million	12.2%
Inventory	AU$5.59 Million	21.6%
Property, Plant & Equipment	AU$6.95 Million	26.9%
Intangible Assets	AU$0.00	0.0%
Goodwill	AU$0.00	0.0%

Asset Composition Trend (2002–2024)

This chart illustrates how Universal Biosensors Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see UBI market cap overview.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Universal Biosensors Inc's current assets represent 71.5% of total assets in 2024, an increase from 0.0% in 2002.
Cash Position: Cash and equivalents constituted 33.1% of total assets in 2024, up from 32.2% in 2002.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2002.
Asset Diversification: The largest asset category is cash and equivalents at 33.1% of total assets.

Universal Biosensors Inc Competitors by Total Assets

Key competitors of Universal Biosensors Inc based on total assets are shown below.

Company	Country	Total Assets
Shenzhen New Industries Biomedical SHE:300832	China	CN¥9.58 Billion
Inspire Medical Systems Inc NYSE:INSP	USA	$911.38 Million
SS Innovations International Inc. Common Stock NASDAQ:SSII	USA	$90.55 Million
Shanghai General Healthy Information and Technology Co. Ltd. SHG:605186	China	CN¥1.59 Billion
Medprin Regenerative Medical Technologies Co. Ltd. SHE:301033	China	CN¥805.10 Million
Stratec SE XETRA:SBS	Germany	€443.38 Million
Scandinavian Medical Solutions AS CO:SMSMED	Denmark	Dkr205.86 Million
Duearity AB ST:DEAR	Sweden	Skr10.84 Million

Universal Biosensors Inc - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	1.90	5.65	3.03
Quick Ratio	1.13	4.45	2.84
Cash Ratio	0.52	0.00	0.00
Working Capital	AU$3.81 Million	AU$21.00 Million	AU$21.93 Million

Universal Biosensors Inc - Advanced Valuation Insights

This section examines the relationship between Universal Biosensors Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	0.59
Latest Market Cap to Assets Ratio	0.11
Asset Growth Rate (YoY)	-13.8%
Total Assets	AU$25.84 Million
Market Capitalization	$2.95 Million USD

Valuation Analysis

Below Book Valuation: The market values Universal Biosensors Inc's assets below their book value (0.11x), which may indicate investor concerns about asset quality or future growth.

Significant Asset Reduction: Universal Biosensors Inc's assets decreased by 13.8% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Universal Biosensors Inc (2002–2024)

The table below shows the annual total assets of Universal Biosensors Inc from 2002 to 2024.

Year	Total Assets	Change
2024-12-31	AU$25.84 Million ≈ $18.28 Million	-13.79%
2023-12-31	AU$29.97 Million ≈ $21.21 Million	-35.05%
2022-12-31	AU$46.15 Million ≈ $32.65 Million	+3.69%
2021-12-31	AU$44.50 Million ≈ $31.49 Million	-21.07%
2020-12-31	AU$56.38 Million ≈ $39.89 Million	-10.02%
2019-12-31	AU$62.66 Million ≈ $44.34 Million	-10.46%
2018-12-31	AU$69.98 Million ≈ $49.51 Million	+51.26%
2017-12-31	AU$46.26 Million ≈ $32.73 Million	-7.46%
2016-12-31	AU$49.99 Million ≈ $35.37 Million	+11.21%
2015-12-31	AU$44.95 Million ≈ $31.81 Million	-5.43%
2014-12-31	AU$47.53 Million ≈ $33.63 Million	-12.98%
2013-12-31	AU$54.62 Million ≈ $38.65 Million	+11.32%
2012-12-31	AU$49.07 Million ≈ $34.72 Million	+8.52%
2011-12-31	AU$45.22 Million ≈ $31.99 Million	-16.01%
2010-12-31	AU$53.84 Million ≈ $38.09 Million	-4.00%
2009-12-31	AU$56.08 Million ≈ $39.68 Million	+2.55%
2008-12-31	AU$54.69 Million ≈ $38.69 Million	-14.36%
2007-12-31	AU$63.86 Million ≈ $45.18 Million	+60.11%
2006-12-31	AU$39.88 Million ≈ $28.22 Million	+823.84%
2005-12-31	AU$4.32 Million ≈ $3.05 Million	+2.01%
2004-12-31	AU$4.23 Million ≈ $2.99 Million	+1.39%
2003-12-31	AU$4.17 Million ≈ $2.95 Million	+168.94%
2002-12-31	AU$1.55 Million ≈ $1.10 Million	--

About Universal Biosensors Inc

AU:UBI Australia Medical Devices

Market Cap

$2.95 Million

AU$4.17 Million AUD

Market Cap Rank

#29486 Global

#1698 in Australia

Share Price

AU$0.01

Change (1 day)

+0.00%

52-Week Range

AU$0.01 - AU$0.04

All Time High

AU$1.00